NYMOX PHARMACEUTICAL CORPORATION Other Finance Cost
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Other Finance Cost of $163.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-30.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OtherFinanceCost · last filed 2020-03-30
| Period end | Other Finance Cost 12 month | Other Finance Cost 12 month as first filed |
|---|---|---|
| 2019-12-31 | $163.00K 20-F · filed 2020-03-30 | |
| 2018-12-31 | $47.00K 20-F · filed 2020-03-30 | |
| 2017-12-31 | -$194.00K 20-F · filed 2020-03-30 | -$204.00K 20-F · filed 2018-03-30 |
| 2016-12-31 | -$240.00K 20-F · filed 2019-03-29 | -$244.00K 20-F · filed 2018-03-30 |
| 2015-12-31 | -$234.00K 20-F · filed 2018-03-30 |